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Summary
Quinolones are broad-spectrum antibiotics effective against both Gram-positive and
Gram-negative bacteria. Reactive oxygen species (ROS) generated by quinolones may da-
mage cell structures and could be a risk to health. The use of vitamin C to reduce such
risks may have the opposite effects: vitamin C in the presence of divalent metal ions can
induce the Fenton reaction, leading to hydroxyl radical (HO·) generation and oxidative da-
mage. The purpose of this study is to evaluate the antioxidant and prooxidant properties
of vitamin C by measuring its effects on both lipid peroxidation and mutagenesis induced
by quinolones nalidixic acid (NLX) or norfloxacin (NOR) in Salmonella typhimurium TA102.
Mutagenicity was evaluated by the Ames test and the results were expressed as (histidine+
revertants/ng of quinolone), while lipoperoxidation was measured as thiobarbituric acid
reactive substances (mmol malondialdehyde/(mL ⋅ h)). The effects of different concentra-
tions of nalidixic acid (10–1000 ng) or norfloxacin (7–700 ng) on S. typhimurium TA102
were studied, employing the S9 mix (liver homogenate from rats pre-treated with Arochlor
1254) in the presence of 10–1000 mg of ascorbic acid (AA) with 0.1 mM FeCl3 or EDTA.
Minimal inhibitory concentrations of NOR and NLX against 25 uropathogenic Escherichia
coli strains were obtained using the plate dilution method in the presence of vitamin C. Vi-
tamin C (1 mg) together with 0.1 mM FeCl3 showed a prooxidant effect in the S9 mix and
enhanced the lipoperoxidation induced by either NOR or NLX. Mutagenic potency was also
increased for both NOR and NLX. When metal ions were chelated with EDTA, ascorbate
showed both antimutagenic and antioxidant properties. Mutagenic potency and lipopero-
xidation were reduced for both NOR and NLX. The addition of vitamin C did not change
the minimal in vitro inhibitory concentrations of NLX or NOR against the 25 uropatho-
genic E. coli strains. The antimutagenic and antioxidant effects of vitamin C were espe-
cially marked when the Salmonella strain was exposed to NOR or NLX in the presence of
EDTA. In contrast, the vitamin C in the presence of FeCl3 increased ROS generation, en-
hancing both the mutagenic effect of the quinolones and malondialdehyde production from
lipoperoxidation induced in the bacterial membranes. Therapeutic use of quinolones together
with vitamin C and divalent cations might induce the Fenton reaction involving norfloxacin
and nalidixic acid. However, our results suggest that vitamin C could be a good alterna-
tive for reducing the genotoxic risk of these therapeutic drugs if it is carefully handled.
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Introduction
Fluoroquinolones are widely-used antibiotics because
they are effective against Gram-positive and Gram-nega-
tive bacteria (1). Their therapeutic use cannot be avoided
even though it has been shown that they induce oxida-
tive damage in Salmonella typhimurium TA102 (2). These
antibiotics are photosensitive mutagens, with toxic and
genotoxic effects that may be due to the singlet oxygen
reactive species (ROS) generated by quinolones that ab-
sorb light energy (3,4). As DNA mutations by ROS are
important in the induction of cancers, it is worthwhile
to evaluate procedures that might reduce this genotoxic
risk. The induction of ROS in S. typhimurium by nalidi-
xic acid (NLX) or norfloxacin (NOR) can be inhibited by
antioxidants such as b-carotene or by plants rich in anti-
oxidants (5,6).
The antimutagenic effects and mechanisms of action
of several vitamins against diverse mutagenic agents (6,7)
have been studied in different short test systems; vita-
min C (ascorbic acid, AA) and b-carotene are particular
examples. While the antimutagenicity of b-carotene was
well demonstrated, vitamin C (AA) only slightly reduced
the genotoxic effects of potent mutagens such as 2-nitro-
furans, according to the Ames test (7–9). In fact, vitamin
C (AA) might have a dual activity. It readily scavenges
reactive oxygen and nitrogen species and may thereby
prevent oxidative damage to important biological macro-
molecules such as DNA, lipids and proteins. On the other
hand, owing to its oxidoreductive properties, AA also
reduces redox-active transition of metal ions in the active
sites of specific biosynthetic enzymes. This interaction
with catalytically active metal ions could contribute to
oxidative damage through the production of hydroxyl
and alkoxyl radicals (10), so AA could behave as a pro-
oxidant rather than an antioxidant and produce adverse
effects. Thus, it significantly increases the frequency of
spontaneous revertants in the S. typhimurium strains
TA102 and TA104, which are sensitive to oxidative mu-
tagens (11), but it can utilize H2O2 during in vitro oxida-
tion and generate hydroxyl radicals in the Fenton type
reaction, inducing non-disulphide covalent cross-links in
biomolecules (12). This study was designed to investi-
gate the antioxidant and prooxidant properties of vita-
min C (AA) on S. typhimurium strain TA102, using nali-
dixic acid (NLX) and norfloxacin (NOR) as mutagenic
and ROS-generating agents, with the Arochlor 1254-in-
duced rat liver (S9 mix) in the presence of Fe3+ ions or
EDTA as metal chelator (13). Mutagenicity was evaluat-
ed by the Ames test and the results were expressed as
histidine+ revertants/ng of quinolone, while lipoperoxi-
dation was determined by the production of thiobarbi-




Norfloxacin (NOR) was kindly donated by Aplica-
ciones Farmacéuticas, SA, México, DF, México. Nalidixic
acid (NLX) was kindly provided by Winthrop Laborato-
ries, SA, México, DF, México. The antibiotics were tested
as chemically pure salts since they are used as commer-
cial preparations. Sodium-L-ascorbate, ampicillin, tetra-
cycline, D-biotin, D-glucose-6-phosphate dipotassium salt
(G6P), b-nicotinamide adenine dinucleotide phosphate
sodium salt (NADP), mitomycin C, 2-aminoanthracene,
1,1,3,3-tetramethoxypropane (malonaldehyde bis(dimeth-
yl acetal)) and 2-thiobarbituric acid were obtained from
Sigma Chemical Co. (St Louis, MO, USA). Dimethylsulph-
oxide (DMSO) and L-histidine were purchased from
Merck, Darmstadt, Germany. Arochlor 1254-induced rat
liver homogenate (S9 mix) was prepared as described by
Maron and Ames (14). S. typhimurium strain TA102
(hisG428, pQ1, pKM101) was kindly provided by Dr B.N.
Ames, University of California (Berkeley, CA, USA). Uro-
pathogenic strains of E. coli were obtained from patients
with symptomatic urinary infections (15).
Mutagenicity assays
Stationary phase cultures of S. typhimurium TA102
were prepared in Nutrient Broth No. 2 (Oxoid) in a
shaking water bath at 37 °C for 16 h. Aliquots (100 mL)
of this culture were exposed to non-bactericidal doses of
antibiotics in screw-top sterile tubes: 0.007–0.7 ng/Petri
dish of NOR or 0.01–1.0 ng/Petri dish of NLX, or to ap-
propriate positive controls: mitomycin C (2 ng/Petri dish)
or 2-aminoanthracene (10 mg/Petri dish). Negative con-
trols (1000 mg/Petri dish) were either the solvent used
(distilled water, 10 mL of 0.1 mM EDTA or 0.1 mM FeCl3),
DMSO, or AA. Assays were performed with or without
500 mL of Arochlor 1254-induced rat liver (S9 mix). Tu-
bes were incubated for 60 min at 37 °C, and 90 rpm in a
Scientific-BF-23 shaking water bath, then 2.0 mL of soft
agar were added, as described in the modified preincu-
bation Ames test (14). The tube contents were mixed in
a vortex, plated on Vogel-Bonner plates and incubated for
48 h at 37 °C. Histidine (His+) revertants were counted
in a Fisher colony-counter.
Antimutagenicity assays
Cultures were exposed to different doses of NOR or
NLX as described above, then 1000, 100 or 10 mg/Petri
dish of AA were added. The AA was dissolved in (i)
distilled water free of metal cations, (ii) 0.1 mM EDTA,
or (iii) 0.1 mM FeCl3, and tested with S9 mix. Negative
and positive controls are described above and the refer-
ence values were the His+ values induced by NOR and
NLX in the absence of AA.
Thiobarbituric acid assay (TBARS)
Tubes (100 mL) of overnight S. typhimurium TA102
cultures were exposed to either NOR or NLX and ascor-
bate under the three different experimental conditions
described above, then 200 mL of 0.6 M H2SO4 and 0.3 M
Na2WO4 were added. After centrifugation (1000×g, 10
min) and addition of 1 mL of 0.375 % thiobarbituric acid,
the mixture was boiled for 15 min. After cooling, 0.5 mL of
HCl were added and the absorbance was read at 535 nm
(16). Malondyaldehyde bis(dimethyl acetal), 1,1,3,3-tetra-
methoxypropane, was used as standard. Lipoperoxida-
tion was measured as thiobarbituric acid reactive sub-
stances (TBARS; mmol of malondialdehyde/(mL ⋅ h)).
Results were calculated as described by Hicks et al. (16).
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In vitro bactericidal studies
Serial dilutions of NOR or NLX of 1:2 were prepar-
ed from stock solutions containing 640 mg/mL of NOR
or NLX in 0.01 M NaOH (0.5 to 320 mg/mL) (17). Volu-
mes of 1 mL of these solutions, with or without 1000 mg
of AA, were poured into sterile Petri dishes. They were
further diluted (1:10) with 9.0 mL of Mueller-Hinton agar
at 45 °C. The plates were gently shaken and allowed to
dry at room temperature overnight. Uropathogenic E. coli
strains were cultured on MacConkey agar and suspen-
sions were adjusted to a McFarland tube no. 0.5 and di-
luted to 1:10. The final strain dilutions deposited on a
Steers replicator were 104 CFU–1. NOR or NLX plates
with or without AA were inoculated with microcolonies.
Initial and final controls of strain growth were also ob-
served. All plates were incubated at 37 °C for 18 h and
the number of resistant strains was evaluated (17).
Statistical methods
Mutagenicity results were considered positive when
the chemical tested induced twice as many His+ rever-
tants as were obtained by spontaneous reversion, and a
dose-response curve was plotted. The gradient of the
curve was estimated by a multivariate ANOVA test,
using Salmonella Assay Analysis software from the US
Environmental Protection Agency. The gradient indicates
the number of His+ revertants induced per ng of qui-
nolone. Antimutagenesis and antioxidant results were
analyzed by Dunnett´s Multiple Comparison test, using
GraphPad Prism software version 2.01.
Results and Discussion
Mutagenicity and antimutagenicity assays
Ascorbic acid (1 mg) slightly increased the sponta-
neous reversion of S. typhimurium TA102 from 263±3.84
to 424.33±47.67, without fitting any of the Maron and
Ames (14) criteria of mutagenicity. These results were si-
milar to those reported by D'Agostini et al. (18), who
found that AA slightly increased the spontaneous rever-
sion of S. typhimurium hisG428 strains. This result show-
ed that AA is suitable for evaluation by this short test
system (Table 1).
When rat liver was exposed to Arochlor 1254 (S9
mix), and the cytochrome P450 (CYP450) was induced
under standard Ames test conditions (14), AA reduced
the mutagenic effects of both NOR and NLX acid on S.
typhimurium hisG428 TA102 in a dose-dependent manner
(Table 1). Chelating of the metal ions on the plate with
0.1 mM EDTA significantly reduced the mutagenic po-
tency of the quinolones compared to the data obtained
under standard Ames test conditions. This result is at-
tributable to the sequestering of ions needed for opti-
mum in vitro metabolic activation in the Ames test. This
problem was partially solved by a twofold increase in
the volume of MgCl2-KCl solution recommended by
Maron and Ames in the S9 mix for in vitro microsomal
Salmonella mutagenicity assays (Table 1, Fig. 1) (14).
When AA was added (Table 1, Figs. 1a and 1c), the mu-
tagenic potencies of NOR and NLX were reduced from
9916 to 1605 and from 8727 to 2351 His+ revertants/ng
of quinolone (p<0.05), respectively. When AA was added
in the presence of FeCl3 and S9 mix, the mutagenic po-
tencies of NOR and NLX were increased from 10800 to
14587 (p<0.05) and from 9052 to 13473 His+ revertants/
ng of quinolones (p<0.001) respectively (Table 1, Figs. 1b
and 1d). These results were statistically significant.
Lipoperoxidation reactions
Under the assay conditions normally employed for
the Ames test, both NOR and NLX induced TBARS in S.
typhimurium membranes. Chelating metal ions with EDTA
resulted in a dose-dependent antioxidant effect of AA
(Fig. 2): TBARS were decreased from 48.5 to 12.8 nmol/
(mL ⋅ h) (p<0.001) for NOR and from 19.6 to 5.86 nmol/
40 M. ARRIAGA-ALBA et al.: Antioxidant and Antimutagenic Capacity of Vitamin C, Food Technol. Biotechnol. 46 (1) 38–43 (2008)








(+S9 mix) none 22402.3* 93.0 9733.0 149.3
10.0 19540.0 529.0 9393.0 910.0
100.0 20400.0 245.0 6257.0 1315.0
1000.0 18850.0 1641.9 3724.0 649.0
(+EDTA) none 9916.0 610.0 8727.0 470.2
10.0 9300.0 871.2 6057.0 172.3
100.0 5035.0 97.5 6011.0 589.2
1000.0 1605.0 181.5 2351.0 504.0
(+FeCl3) none 10800.0 1183.0 9052.8 282.5
10.0 10870.0 1037.0 10778.0 65.5
100.0 11547.5 919.0 10472.0 120.0
1000.0 14587.0 368.5 13472.6 1750.0
*Mutagenic potency calculated as the induced revertants by the gradient, expressed as His+ revertants induced by 1 ng of quinolone.
Values were obtained by multi-variance analysis using SALANAL software (EPA, USA). S.D.: standard deviation. The mutagenic po-
tency of ascorbic acid alone was 0.04886±0.016
(mL ⋅ h) (p<0.001) for NLX (Figs. 2a and 2c). In contrast,
AA in the presence of Fe3+ increased the oxidant effect
of quinolones: it enhanced the measurable TBARS in-
duced by NOR and NLX from 25.9 to 75.6 nmol/(mL ⋅ h)
and 18 to 35 nmol/(mL ⋅ h), respectively (p<0.001) (Figs.
2b and 2d).
In vitro bactericidal studies
Among the uropathogenic strains evaluated, 16.6 %
were resistant to NOR and 33.5 % were resistant to NLX.
The addition of vitamin C dissolved in distilled water
did not affect the resistance to these antibiotics with or
without the S9 mix.
The C-5 fluoroquinolone, norfloxacin (NOR), is a po-
tent antibiotic which induces mutation independently of
structural changes that may occur through in vitro meta-
bolism. It has been shown to induce oxidative damage
in S. typhimurium TA102 (2,3). After incubation for 60 min
at 37 °C and 90 rpm, as described in the Materials and
Methods section, NOR shows high mutagenic potency
towards S. typhimurium TA102. Under these assay condi-
tions, AA reduced its mutagenic potency only slightly
(Table 1). Our results agree with those reported by Bala
and Grover (9), who used distilled water under standard
Ames test conditions and reported that AA was only
weakly antimutagenic when it was added in a chemi-
cally pure form or as citrus juice to potent mutagens.
Similar data were also reported by Gajewska et al. (8),
who showed that the effects of the potent mutagens ni-
trofurazone and furazolidone on S. typhimurium TA98 and
TA102 were slightly reduced by AA under the Ames test
conditions. In contrast, the mutagenic potency of NLX, a
less potent mutagen, was reduced in a dose-dependent
way by the antioxidant effect of AA (Table 1).
When EDTA was used to sequester the divalent ions
present in distilled water, the antimutagenicity of AA was
enhanced against both NOR and NLX (Table 1, Fig. 1).
The use of weaker, naturally-occurring chelators must be
further evaluated to identify the one that can reduce the
genotoxic risk of the Fenton reaction without interfering
with normal iron metabolism (13). When the mutageni-
city assays were performed in the presence of Fe3+, the
mutagenic potency was reduced, probably because the
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Fig. 1. Antimutagenic activity of ascorbic acid (AA) against mutations induced by: (a) norfloxacin (NOR) in a cation-free medium,
(b) norfloxacin (NOR) in Fe3+ solution, (c) nalidixic acid (NLX) in a cation-free medium, (d) nalidixic acid (NLX) in Fe3+ solution.
Each point is the mean of six plates from two independent assays. Salmonella typhimurium TA102 spontaneous reversion: 325±45.80.
Positive controls: mitomycin C, 2 ng/plate, 2543±83.10; 2-aminoanthracene, 10 µg/plate, 2113.00±190.33. Each point represents the
mean of nine Petri dishes from three independent assays. AA in Fe3+ solution, 433±71.24; in EDTA, 440±28.90
cytochrome P450 oxidase system was less efficient and
less able to metabolize the quinolones (Table 1). Instead
of being an antimutagen under these conditions, AA in-
creases the DNA damage induced by quinolones. These
results are consistent with other reports, which indicate
that vitamin C (AA) induces the Fenton reaction, pro-
ducing DNA breaks and biomolecule damage and en-
hances the genotoxicity of drugs (13,19). The value of
antimutagens in reducing genotoxic risk is still uncer-
tain, despite several years of study and several assays
on naturally-occurring plant derivatives (20). The inter-
action of antioxidants with other organic and inorganic
compounds needs to be further evaluated. Espinosa-
-Aguirre et al. (21) reported that high doses of a complex
mixture of chili extract, which also contains ascorbic acid
and inorganic compounds, enhance the mutagenic po-
tency of aromatic hydrocarbons present in polluted air
samples, rather than reducing it, as observed with pure
antioxidants (21). From our results, it is possible to con-
sider the participation of ROS generated by both NOR
and NLX (4) in the lipoxygenation process indicative of
cell membrane breakdown and DNA-damaging mutage-
nicity in S. typhimurium strains (Fig. 2).
In fact, it is well known that quinolones that decom-
pose without generating singlet oxygen may still form
ROS or give rise to toxic breakdown products (22), pro-
ducing mutagenic effects at the A/T hot-points in S.
typhimurium TA102 strains. Metabolic activation by the
NADP-CYP450 oxidase chain (S9 mix), used under the
Ames test conditions, involves direct electron transfer
from the quinone group to AA, producing ascorbyl free
radicals (23) that lead to DNA oxidation (a mutagenic
effect) and ascorbyl radical monoelectronic reduction,
generating semidehydroascorbic acid (24). A similar ef-
fect might be produced in the presence of iron. AA can
be an antioxidant or prooxidant agent, depending on
chemical or physiological conditions. Franke et al. (25)
also reported a dual effect of higher and lower doses of
AA employed to reduce genotoxic damage induced by
methylmethanesulphonate using the comet assay. Ascor-
bate reduces ferric to ferrous iron, producing the chemi-
cal conditions for the Fenton reaction (26). The results
presented here support the possibility that AA in the
presence of free iron and CYP450 enhances the oxidative
damage to DNA induced by quinolones. Our results are
consistent with the evidence that a combination of AA
and iron induces the Fenton reaction in the presence of
certain phenolic compounds that can induce DNA breaks,
biomolecule damage and increase drug genotoxicity. In-
deed, Li et al. (27) reported that when DNA breaks were
induced by the Fenton reagent (ascorbate plus iron), four
different phenolic compounds added in vitro inhibited the
oxidative injury because of their scavenging properties.
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Fig. 2. Antioxidant activity of ascorbic acid (AA) against lipoperoxidation (TBARS) induced in S. typhimurium TA102 by: (a) norfloxa-
cin (NOR) in a cation-free medium, (b) norfloxacin (NOR) in Fe3+ solution, (c) nalidixic acid (NLX) in a cation–free medium, (d)
nalidixic acid (NLX) in Fe3+ solution; TBARS, (nmol/(mL ⋅ h)). Each point represents the average of three independent assays
Conclusions
The role of vitamin C (AA) in vivo has been studied
widely, but there are still many contradictory results.
Carr and Frei (10) also reported that AA increases al-
koxyl and hydroxyl ion production when free metal ions
are present, but the effect of these reactions in vivo needs
further study. Some in vivo studies failed to demonstrate
prooxidation activity by the measurement of DNA da-
mage in human volunteers, perhaps because sufficient
free iron was not available in those patients (28). Ne-
vertheless, vitamin C in commercial formulae, combined
with minerals, must be used with care on patients with
infectious diseases during quinolone treatment. On the
other hand, low doses of AA (1 mg daily) reduce quino-
lone-induced mutations, so the consumption of fruits and
vegetables rich in AA, avoiding free iron ions, may be a
good alternative for decreasing the oxidative damage
generated by these therapeutic drugs.
Acknowledgements
We thank Gabriela Aguilera Hernandez for the cul-
ture medium preparation.
References
1. J.M. Domagala, Structure activity and structure side-effects
relationships for quinolone antibacterials, J. Antimicrob. Che-
mother. 33 (1994) 685–706.
2. M. Arriaga-Alba, F. Barron-Moreno, R. Flores-Paz, E. Gar-
cía-Jimenez, Genotoxic evaluation of norfloxacin and pipe-
midic acid with the Escherichia coli PolA-/PolA+ and the
Ames test, Arch. Med. Res. 29 (1998) 235–240.
3. D.G. Robertson, G.A. Epling, J.S. Kelly, D.L. Bailey, B. Song,
Mechanistic studies on the phototoxic potential of PD
117596, a quinolone antibacterial compound, Toxicol. Appl.
Pharmacol. 111 (1991) 221–232.
4. E. Goke, Photochemical mutagenesis: Examples and toxi-
cological relevance, J. Environ. Pathol. Toxicol. Oncol. 20 (2001)
285–292.
5. M. Arriaga-Alba, R. Rivera-Sánchez, G. Parra-Cervantes, F.
Barron-Moreno, R. Flores-Paz, E. Garcia-Jiménez, Antimu-
tagenesis of b-carotene to mutations induced by quinolone
on Salmonella typhimurium, Arch. Med. Res. 31 (2000) 156–161.
6. M. Reyes–López, S. Villa-Treviño, M. Arriaga-Alba, L. Ale-
mán-Lazarini, M. Rodríguez-Mendiola, C. Arias-Castro, S.
Fattel-Fazenda, M. de la Garza, The amoebicidal aqueous
extract from Castela texana possesses antigenotoxic and an-
timutagenic properties, Toxicol. in vitro, 19 (2005) 91–97.
7. R. Edenharder, A. Worf-Waldelburg, M. Decker, K.L. Platt,
Antimutagenic effects and possible mechanisms of action
of vitamins and related compounds against genotoxic he-
terocyclic amines from cooked food, Mutat. Res. 444 (1999)
235–248.
8. J. Gajewska, M. Szczyka, B. Tudek, T. Szymczyk, Studies
on the effect of ascorbic acid and selenium on the genoto-
xicity of nitrofurans: nitrofurazone and furazolidone, Mu-
tat. Res. 232 (1999) 191–197.
9. S. Bala, I.S. Grover, Antimutagenicity of some citrus fruits
in Salmonella typhimurium, Mutat. Res. 222 (1989) 141–148.
10. A. Carr, B. Frei, Does vitamin C act as a pro-oxidant under
physiological conditions?, FASEB J. 13 (1999) 1007–1024.
11. D. Levin, M. Hollstein, M. Christman, E. Schwiers, B.N.
Ames, A new Salmonella tester strain (TA102) with AT pairs
at the site of mutation detects oxidative mutagens, Proc.
Natl. Acad. Sci. USA, 70 (1982) 7445–7449.
12. A. Sur, K. Pal, S. Sen, S. Chakrabarti, Ascorbate induced
cross-linking of oxyhemoglobin subunits, Indian J. Exp. Biol.
38 (2000) 280–282.
13. J.B. Galey, O. Destrée, J. Dumats, P. Pichaud, J. Marché, S.
Génard, G. Bracciolli, L. Le Capitaine, H. Plessix, L. Bram-
billa, O. Cantoni, Protection of U937 cells against oxidative
injury by a novel series of iron chelators, Free Radic. Biol.
Med. 25 (1998) 881–890.
14. D.M. Maron, B.N. Ames, Revised methods for the Salmo-
nella typhimurium mutagenicity test, Mutat. Res. 13 (1983)
173–215.
15. M. Arriaga-Alba, R. Rivera-Sánchez, G. Romero-Díaz, N.
Hernando-Aguilar, Frequency of colicin and hemolysins in
Escherichia coli isolated from pregnant patients with symp-
tomatic and asymptomatic urinary tract infection, Ginecol.
Obstet. Méx. 68 (2000) 275–281 (in Spanish).
16. J.J. Hicks, R. Medina-Navarro, A.M. Guzman-Grenfell, N.
Wacher, A. Lifshiz, Possible effect of air pollutants (Mexico
City) on superoxide dismutase activity and serum lipoper-
oxides in the human adult, Arch. Med. Res. 27 (1996) 145–
149.
17. Methods for Dilution Antimicrobial Susceptibility Test for
Bacteria that Grow Aerobically – Fifth Edition: Approved
Standard M7-A5, NCCLS, Wayne, PA, USA (2000).
18. F. D'Agostini, R.M. Balansky, A. Camoirano, S. De Flora,
Interactions between N-acetylcysteine and ascorbic acid in
modulating mutagenesis and carcinogenesis, Int. J. Cancer,
88 (2000) 702–707.
19. M. Matsumoto, K. Kajima, H. Nagano, S. Matsubara, T.
Yokota, Photostability and biological activity of fluoroqui-
nolones substituted at the 8-position after UV irradiation,
Antimicrob. Agents Chemother. 36 (1992) 1715–1719.
20. M. Gonzalez-Avila, M. Arriaga-Alba, M. de la Garza, M.C.
Hernedez-Pretelin, M.A. Dominguez-Ortiz, S. Fattel-Fazen-
da, S. Villa-Trevino, Antimutagenic and ROS scavenging
activities of a Rhoeo discolor ethanolic crude extract, Toxicol.
in vitro, 17 (2003) 77–83.
21. J.J. Espinosa-Aguirre, R.E. Reyes, J. Rubio, P. Ostrosky-Weg-
man, G. Martinec, Mutagenic activity of urban air samples
and its modulation by chili extracts, Mutat. Res. 303 (1993)
55–61.
22. L. Marrot, J.P. Belaidi, C. Perez, L. Riou, A. Sarasin, J.R.
Meunier, Molecular responses to photogenotoxic stress in-
duced by the antibiotic lomefloxacin in human skin cells:
From DNA damage to apoptosis, J. Invest. Dermatol. 12 (2003)
596–606.
23. C. Courderot-Masuyer, J.J. Lahet, B. Verges, J.M. Brun, L.
Rochette, Ascorbyl free radical release in diabetic patients,
Cell. Mol. Biol. 46 (2000) 1397–1401.
24. M.P. Sierra-Vargas, A.M. Guzmán-Grenfell, I.M. Olivares-
-Corichi, Y.D. Torres Ramos, J.J. Hicks, Reactive Oxygen Spe-
cies (ROS) participation in pulmonary diseases, Rev. Inst.
Enf. Resp. Mex. 17 (2004) 135–148.
25. S.I. Franke, D. Para, J. da Silva, B. Erdtmann, J.A. Henri-
ques, Possible repair action of vitamin C on DNA damage
induced by methyl methanesulfonate, cyclophosphamide,
FeSO4 and CuSO4 in mouse blood cells in vivo, Mutat. Res.
583 (2005) 75–84.
26. M. Yang, C.S. Collins, M. Kelly, A.T. Diplock, C. Rice-Evans,
Does iron and vitamin C co-supplementation influence pla-
telet function or LDL oxidizability in healthy volunteers?,
Eur. J. Clin. Nutr. 53 (1999) 367–374.
27. A.S. Li, B. Bandy, S.S. Tsang, A.J. Davison, DNA-breaking
versus DNA-protecting activity of four phenolic compounds
in vitro, Free Radic. Res. 33 (2000) 551–566.
28. A.R. Proteggente, A. Rehman, B. Halliwell, C.A. Rice-Evans,
Potential problems of ascorbate and iron supplementation:
Pro-oxidant effect in vivo?, Biochem. Biophys. Res. Commun.
227 (2000) 535–540.
43M. ARRIAGA-ALBA et al.: Antioxidant and Antimutagenic Capacity of Vitamin C, Food Technol. Biotechnol. 46 (1) 38–43 (2008)
